Sushmi Dey

Stories by Sushmi Dey

All life-saving drugs may come under price cap

All life-saving drugs may come under price cap

Rediff.com   25 Oct 2014

NPPA suggests expanding the list of essential medicines whose prices are controlled

Gujarat to get biggest share of 'Make in India' pie

Gujarat to get biggest share of 'Make in India' pie

Rediff.com   24 Oct 2014

Domestic and foreign companies pour in a slew of investments in Gujarat.

Ranbaxy staff get pay-cut shield in Sun buyout

Ranbaxy staff get pay-cut shield in Sun buyout

Rediff.com   20 Oct 2014

Sun maintained it would retain the best of both organisations to build a global pharma company.

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Rediff.com   15 Oct 2014

A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.

Ranbaxy's top executives in the US resign

Ranbaxy's top executives in the US resign

Rediff.com   14 Oct 2014

US country head, key departmental heads leave; more likely to follow.

Less competition, demand-supply gap push US drug prices

Less competition, demand-supply gap push US drug prices

Rediff.com   13 Oct 2014

Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.

Is India ready to fight Ebola? NO WAY!

Is India ready to fight Ebola? NO WAY!

Rediff.com   10 Oct 2014

No Ebola case detected in the country so far; experts say a robust preparedness plan to fight the virus missing.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com   9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Pharma firms to be hit as drug regulator caps prices

Pharma firms to be hit as drug regulator caps prices

Rediff.com   19 Sep 2014

Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Rediff.com   15 Sep 2014

Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides Arcolab and Mylan, while Cipla is expected to earn active pharmaceutical ingredient rights.

Sun Pharma draws up plan to fix ailing Ranbaxy

Sun Pharma draws up plan to fix ailing Ranbaxy

Rediff.com   12 Sep 2014

It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues

Drug price monitoring cells across states soon

Drug price monitoring cells across states soon

Rediff.com   8 Sep 2014

The idea is to keep a close watch on real-time price movements, the maximum retail price of medicines and their availability.

Govt to reverse brain drain, bring back NRI scientists

Govt to reverse brain drain, bring back NRI scientists

Rediff.com   3 Sep 2014

The Ministry of Science and Technology has approached about a dozen well-known scientists from across the world in an effort to bring them back to various departments under the ministry, said Jitendra Singh, minister of state (independent charge) for science and technology.

FDI policy for medical devices on the cards

FDI policy for medical devices on the cards

Rediff.com   31 Aug 2014

Ministerial consultations on, with recognition of the potential, and the need to not classify it under the same rules as for pharmaceuticals.

Another big blow for Ranbaxy

Another big blow for Ranbaxy

Rediff.com   22 Aug 2014

Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.

US FDA India head quits; regulator goes for rejig

US FDA India head quits; regulator goes for rejig

Rediff.com   21 Jul 2014

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.

Sun, Ranbaxy hire Mckinsey for merger assistance

Sun, Ranbaxy hire Mckinsey for merger assistance

Rediff.com   18 Jul 2014

Sun-Ranbaxy are keen to complete the merger process.

Drug makers seek out-of-court settlement in clinical trial cases

Drug makers seek out-of-court settlement in clinical trial cases

Rediff.com   10 Jun 2014

In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.

Drug makers told to give pricing details in 10 days

Drug makers told to give pricing details in 10 days

Rediff.com   6 Jun 2014

The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.

Now, buy medicines and stents on EMI

Now, buy medicines and stents on EMI

Rediff.com   5 Jun 2014

The company did not respond to specific queries on the project's expansion.